This inventor holds 7 USPTO granted patents and 8 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignees: Abbvie Inc., Abbott Laboratories Corporation. Active years: 2011-2019.
Company Filing History:
Years Active: 2011-2019
Title: Grier A Wallace: Innovator in Pharmaceutical Compounds
Introduction
Grier A Wallace is a notable inventor based in Sterling, MA (US), recognized for his contributions to the field of pharmaceuticals. With a total of seven patents to his name, Wallace has made significant advancements in the treatment of immunological and oncological conditions.
Latest Patents
Among his latest patents, Wallace has developed tricyclic compounds that provide compounds of Formula (I) and Formula (II), including pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers, and isomers. These compounds are designed to be effective in treating various immunological and oncological conditions. Additionally, he has created primary carboxamides as BTK inhibitors, which also include compounds of Formula (I) and their respective variants, aimed at addressing similar health issues.
Career Highlights
Throughout his career, Grier A Wallace has worked with prominent companies such as AbbVie Inc. and Abbott Laboratories Corporation. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to groundbreaking research.
Collaborations
Wallace has collaborated with notable colleagues, including Kristine E Frank and Michael M Friedman, enhancing the collaborative efforts in his research and development projects.
Conclusion
Grier A Wallace stands out as an influential inventor in the pharmaceutical industry, with a focus on developing innovative compounds for treating critical health conditions. His work continues to impact the field positively.